These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in vivo activity. Abouzid K; Bekhit SA Bioorg Med Chem; 2008 May; 16(10):5547-56. PubMed ID: 18430576 [TBL] [Abstract][Full Text] [Related]
6. Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold. Bakr RB; Ghoneim AA; Azouz AA Bioorg Chem; 2019 Jul; 88():102964. PubMed ID: 31075742 [TBL] [Abstract][Full Text] [Related]
7. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids. Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and anti-inflammatory assessment of certain substituted 1,2,4-triazoles bearing tetrahydroisoquinoline scaffold as COX 1/2-inhibitors. Abo-Elmagd MI; Hassan RM; Aboutabl ME; Amin KM; El-Azzouny AA; Aboul-Enein MN Bioorg Chem; 2024 Sep; 150():107577. PubMed ID: 38941697 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel halogenated triarylpyrazoles as selective COX-2 inhibitors: Anti-inflammatory activity, histopatholgical profile and in-silico studies. Abdellatif KRA; Abdelall EKA; Labib MB; Fadaly WAA; Zidan TH Bioorg Chem; 2020 Dec; 105():104418. PubMed ID: 33166844 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3-c]pyrazol-4(1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors. Grover J; Kumar V; Sobhia ME; Jachak SM Bioorg Med Chem Lett; 2014 Oct; 24(19):4638-4642. PubMed ID: 25219899 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, COX-2 inhibition, anti-inflammatory activity, molecular docking, and histopathological studies of new pyridazine derivatives. Ewieda SY; Hassan RA; Ahmed EM; Abdou AM; Hassan MSA Bioorg Chem; 2024 Sep; 150():107623. PubMed ID: 39002251 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, evaluation and molecular modelling studies of some novel 5,6-diphenyl-1,2,4-triazin-3(2H)-ones bearing five-member heterocyclic moieties as potential COX-2 inhibitors: A hybrid pharmacophore approach. Banerjee AG; Das N; Shengule SA; Sharma PA; Srivastava RS; Shrivastava SK Bioorg Chem; 2016 Dec; 69():102-120. PubMed ID: 27750057 [TBL] [Abstract][Full Text] [Related]